Missed GME or NVDA? Donโt Miss the Next One.โ
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Euda Health Holdings Ltd. (EUDA) Stock Forecast & Price Prediction Singapore | NASDAQ | Real Estate | Real Estate Services
$3.71
+0.33 (9.76%)Did EUDA Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Euda Health is one of their latest high-conviction picks.
Wall Street analysts covering EUDA have a bullish consensus with a median price target of $6.00 (ranging from $6.00 to $6.00). Currently trading at $3.71, the median forecast implies a 61.7% upside. This outlook is supported by 1 Buy, 0 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for EUDA.
Date | Firm | Analyst | Rating | Change | Price Target |
---|
The following stocks are similar to Euda Health based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Euda Health Holdings Ltd. has a market capitalization of $137.85M with a P/E ratio of 0.0x. The company generates $4.01M in trailing twelve-month revenue with a 19.0% profit margin.
Revenue growth is +10.5% quarter-over-quarter, while maintaining an operating margin of -47.1% and return on equity of +597.1%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Integrated healthcare service provider.
The company generates revenue by offering a comprehensive suite of medical services, including primary care, specialist consultations, and therapeutic services through its network of clinics and medical facilities. By focusing on patient-centric approaches and incorporating digital health solutions, it enhances service delivery and patient engagement.
Euda Health Holdings Ltd. is critical in regions that require efficient healthcare access, contributing to public health outcomes and advancing healthcare innovation and service quality.
Real Estate
Real Estate Services
117
Mr. Alfred Lim
Singapore
2021
Preliminary discussions are ongoing to establish a joint venture, indicating potential collaboration and investment opportunities.
Preliminary discussions for a joint venture may indicate potential growth opportunities, risk-sharing, and increased market presence, influencing investor confidence and stock valuations.
The 74th Emerging Growth Conference is scheduled for August 21-22, 2024, as announced by EmergingGrowth.com, a key platform for small cap investment insights.
The Emerging Growth Conference showcases small cap companies, potentially highlighting investment opportunities and trends in emerging sectors, influencing market sentiment and stock movements.
EUDA Health Holdings Limited has completed the acquisition of CK Health Plus Sdn Bhd, expanding its digital healthcare ecosystem in Malaysia and enhancing its regional presence.
EUDA's acquisition of CK Health enhances its market position in Southeast Asia's digital healthcare sector, potentially driving growth and investor confidence through expanded services and reach.
EUDA Health Holdings Limited (NASDAQ: EUDA) will acquire CK Health Plus Sdn Bhd, a Malaysian wellness product seller, expanding its Southeast Asian digital healthcare ecosystem.
EUDA's acquisition of CK Health expands its market presence in Southeast Asia, potentially increasing revenue streams and enhancing its digital healthcare ecosystem, which may attract investor interest.
EUDA Health Holdings Limited received a notice from Nasdaq for failing to maintain a market value of $35 million over 30 consecutive business days, as per listing requirements.
EUDA Health's failure to meet Nasdaq's market value requirement raises concerns about its financial health, potentially affecting stock price and investor confidence.
EUDA Health Holdings Limited received a notice from Nasdaq for failing to maintain a market value of $35 million for 30 consecutive business days, violating Listing Rule 5550(b)(2).
EUDA Health Holdings has failed to meet Nasdaq's minimum market value requirement, risking delisting, which could significantly impact its stock price and investor confidence.
Based on our analysis of 0 Wall Street analysts, Euda Health Holdings Ltd. (EUDA) has a median price target of $6.00. The highest price target is $6.00 and the lowest is $6.00.
According to current analyst ratings, EUDA has 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $3.71. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict EUDA stock could reach $6.00 in the next 12 months. This represents a 61.7% increase from the current price of $3.71. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company generates revenue by offering a comprehensive suite of medical services, including primary care, specialist consultations, and therapeutic services through its network of clinics and medical facilities. By focusing on patient-centric approaches and incorporating digital health solutions, it enhances service delivery and patient engagement.
The highest price target for EUDA is $6.00 from at , which represents a 61.7% increase from the current price of $3.71.
The lowest price target for EUDA is $6.00 from at , which represents a 61.7% increase from the current price of $3.71.
The overall analyst consensus for EUDA is bullish. Out of 0 Wall Street analysts, 1 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $6.00.
Stock price projections, including those for Euda Health Holdings Ltd., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.